NIAID: AstraZeneca may have included 'outdated information' in US clinical trial study

In response to AstraZeneca’s covid vaccine trial findings, the National Institute of Allergy and Infectious Diseases (NIAID) said in its statement on Tuesday, the Anglo-Swedish drugmaker may have included 'outdated information' in the US clinical trial findings.

more to come ....